- Report
- January 2025
- 181 Pages
Global
From €3973EUR$4,500USD£3,471GBP
- Report
- January 2025
- 89 Pages
Global
From €3500EUR$4,246USD£3,165GBP
- Report
- July 2025
Global
From €6622EUR$7,500USD£5,785GBP
- Newsletter
- August 2025
- 75 Pages
Global
€4194EUR$4,750USD£3,664GBP
- Report
- November 2022
- 121 Pages
Brazil
From €5254EUR$5,950USD£4,590GBP
- Report
- August 2024
- 150 Pages
Global
From €3311EUR$3,750USD£2,893GBP
- Report
- April 2023
- 115 Pages
Global
From €4194EUR$4,750USD£3,664GBP
- Report
- May 2024
- 200 Pages
Global
From €3664EUR$4,150USD£3,201GBP
- Report
- January 2024
- 200 Pages
Global
From €3664EUR$4,150USD£3,201GBP
- Report
- February 2024
- 218 Pages
Global
€4410EUR$4,995USD£3,853GBP
- Report
- December 2023
- 391 Pages
Global
€4410EUR$4,995USD£3,853GBP
- Report
- November 2023
- 125 Pages
Global
From €3500EUR$4,246USD£3,165GBP

The Bone Morphogenetic Protein (BMP) market is a subset of the biomaterials industry. BMPs are proteins that can induce bone and cartilage formation, and are used in a variety of medical applications, such as spinal fusion, fracture repair, and dental implants. BMPs are typically derived from recombinant DNA technology, and are used in combination with other biomaterials, such as ceramics, polymers, and metals.
The BMP market is expected to grow in the coming years, driven by the increasing demand for bone and cartilage regeneration, as well as the development of new technologies and products. Additionally, the increasing prevalence of chronic diseases, such as osteoporosis, is expected to drive the demand for BMPs.
Some of the major companies in the BMP market include Medtronic, Stryker, Zimmer Biomet, DePuy Synthes, and Smith & Nephew. These companies are involved in the development, manufacturing, and marketing of BMPs and related products. Show Less Read more